Table 2.

Comparison of clinical baseline characteristics between tranexamic acid group and non-tranexamic acid group

	Tranexamic acid group	Non-tranexamic acid group	Statistics*	P-value
	N = 146 (52.0%)	N = 158 (48.0%)
Gender			0.338	0.561
Male	24 (16.4%)	30 (19.0%)
Female	122 (83.6%)	128 (81.0%)
Age (years)	66.44 ± 6.84	65.70 ± 7.82	0.870	0.385
Hypertension	90 (61.6%)	83 (52.5%)	2.569	0.109
Diabetes mellitus	23 (15.8%)	22 (13.9%)	0.201	0.654
Cardiovascular diseases	17 (11.6%)	29 (18.4%)	2.661	0.103
Cerebral infarction	15 (10.3%)	10 (6.3%)	1.565	0.211
Anticoagulation therapy			0.000	0.986
Rivaroxaban	87 (59.6%)	94 (59.5%)
LMWH	59 (40.4%)	64 (40.5%)

Notes:

^*For normally distributed data, differences between groups were compared by Student’s t-test and shown as T-statistics. For categorical data, differences between groups were compared by Pearson’s chi-squared test and shown as χ²-statistics.

Abbreviation: LMWH, low-molecular-weight heparin.